Pancreatic cancer

JD Mizrahi, R Surana, JW Valle, RT Shroff - The Lancet, 2020 - thelancet.com
Pancreatic cancer is a highly fatal disease with a 5-year survival rate of approximately 10%
in the USA, and it is becoming an increasingly common cause of cancer mortality. Risk …

[HTML][HTML] Pancreatic cancer in 2021: What you need to know to win

V Tonini, M Zanni - World Journal of Gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …

Clinical trials of systemic chemotherapy for resectable pancreatic cancer: a review

MN Mavros, D Moris, PJ Karanicolas, MHG Katz… - JAMA …, 2021 - jamanetwork.com
Importance Adjuvant chemotherapy is the standard of care for resected pancreatic ductal
adenocarcinoma (PDAC) based on level 1 evidence, but some studies suggest that a …

Patient-reported outcomes of video-assisted thoracoscopic surgery versus thoracotomy for locally advanced lung cancer: a longitudinal cohort study

X Wei, H Yu, W Dai, Y Mu, Y Wang, J Liao… - Annals of surgical …, 2021 - Springer
Background The effects of video-assisted thoracoscopic surgery (VATS) and traditional
thoracotomy with respect to patient-reported outcomes (PROs) have only been assessed for …

Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority …

J Jin, Y Shi, M Chen, J Qian, K Qin, Z Wang, W Chen… - Trials, 2021 - Springer
Background Pancreatoduodenectomy is a complex and challenging procedure that requires
meticulous tissue dissection and proficient suturing skills. Minimally invasive surgery with …

Textbook oncologic outcome is associated with increased overall survival after esophagectomy

S Kulshrestha, C Bunn, PM Patel, PJ Sweigert, E Eguia… - Surgery, 2020 - Elsevier
Background Assessment of quality in oncologic operations traditionally involves use of
discrete metrics reported individually. Such metrics have limited value to payers and patients …

Evolving pancreatic cancer treatment: From diagnosis to healthcare management

M Milella, C Bassi, U Boggi, O Brunetti… - Critical Reviews in …, 2022 - Elsevier
The prognosis of pancreatic ductal adenocarcinoma is still the worst among solid tumors. In
this review, a panel of experts addressed the main unanswered questions about the clinical …

Surgical treatment of distal cholangiocarcinoma

L Gorji, EW Beal - Current oncology, 2022 - mdpi.com
Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of
the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients …

Development and evaluation of a navigation-based, multilevel intervention to improve the delivery of timely, guideline-adherent adjuvant therapy for patients with head …

EM Graboyes, KR Sterba, H Li, GW Warren… - JCO Oncology …, 2021 - ascopubs.org
PURPOSE: More than half of patients with head and neck squamous cell carcinoma
(HNSCC) experience a delay initiating guideline-adherent postoperative radiation therapy …

The impact of preoperative oral nutrition supplementation on outcomes in patients undergoing gastrointestinal surgery for cancer in low-and middle-income countries …

SR Knight, AU Qureshi, TM Drake, MCM Lapitan… - Scientific Reports, 2022 - nature.com
Malnutrition is an independent predictor for postoperative complications in low-and middle-
income countries (LMICs). We systematically reviewed evidence on the impact of …